Researchers

Researchers

Professors

Professor Janusz Szemraj, MD, PhD specializes in molecular biology. He graduated in biology at the University of Lodz. He received a doctoral degree in the Department of Biochemistry at the Medical Academy in Łódź (1993). He obtained the postdoctoral degree in the Department of Medical Biochemistry at the Medical University of Lodz (2007). The title of professor of medical science given by the decision of the President of the Republic of Poland (2014). In 1993-97 he completed scientific internships at M.D. Anderson Cancer Center, University of Texas, Houston, USA, and in 2000-2001 at AMC. Cancer Research Center, University of Colorado, Denver, USA. Winner of several dozens of awards and distinctions, including in 1998, the Women’s Association for Breast Cancer Research (Denver, USA), the Individual Award of the Minister of Health in 2013, or the Individual Award for the Lifetime Rector of the Medical University in 2017. He manages the Department of Medical Biochemistry at the Department of Medical Biochemistry at the Medical University of Lodz and the Medical Faculty at the Lazarski University. From 2015, he was employed as a scientific leader in the Bionanopark laboratories. Member of the Scientific Council of the Medical Biology Center of the Polish Academy of Sciences (2012-2020), the Senate Committee for Publishing Affairs (2004-2008) and the Senate Committee for Science of the University of Lodz in 2016-2020. Reviewer of academic grants at NCN, NCBR, expert in the NCN panel. Author and co-author of 7 chapters in textbooks. 300 congress reports at national and international conferences. Author of 216 scientific papers, including original and casuistic, published in peer-reviewed foreign journals 200 works IF 741,12 MNiSW 3605, Index H = 25, citation of works: 2226 (2014 without own citations).

SELECTED PUBLICATIONS FROM THE LAST 10 YEARS:
1. Pawełczyk T, Grancow-Grabka M, Trafalska E, Szemraj J, Żurner N, Pawełczyk A.Telomerase level increase is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: Secondary outcome analysis of the OFFER randomized clinical trial. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Dec 11. pii: S0278-5846(17)30635-8.
2. Świtlik W, Karbownik MS, Suwalski M, Kozak J, Szemraj J miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study. Cancer Biomark. 2017 Oct 27. doi: 10.3233/CBM-170767. [Epub ahead of print]
3. Sliwinska A, Sitarek P, Toma M, Czarny P, Synowiec E, Krupa R, Wigner P, Bialek K, Kwiatkowski D, Korycinska A, Majsterek I, Szemraj J, Galecki P, Sliwinski T Decreased expression level of BER genes in Alzheimer’s disease patients is not derivative of their DNA methylation status. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):311-316. doi: 10.1016/j.pnpbp.2017.07.010. Epub 2017 Jul 11.
4. Pawełczyk T, Grancow-Grabka M, Trafalska E, Szemraj J, Pawełczyk A Oxidative stress reduction related to the efficacy of n-3 polyunsaturated fatty acids in first episode schizophrenia: Secondary outcome analysis of the OFFER randomized trial. Prostaglandins Leukot Essent Fatty Acids. 2017 Jun;121:7-13. doi: 10.1016/j.plefa.2017.05.004. Epub 2017 May 26.
5. Krupa R, Czarny P, Wigner P, Wozny J, Jablkowski M, Kordek R, Szemraj J, Sliwinski T The Relationship Between Single-Nucleotide Polymorphisms, the Expression of DNA Damage Response Genes, and Hepatocellular Carcinoma in a Polish Population. DNA Cell Biol. 2017 Aug;36(8):693-708. doi: 10.1089/dna.2017.3664. Epub 2017 Jun 9.
6. Witusik-Perkowska M, Zakrzewska M, Sikorska B, Papierz W, Jaskolski DJ, Szemraj J, Liberski PP Glioblastoma-derived cells in vitro unveil the spectrum of drug resistance capability – comparative study of tumour chemosensitivity in different culture systems. Witusik.Biosci Rep. 2017 Jun 21;37(3). pii: BSR20170058. doi: 10.1042/BSR20170058. Print 2017 Jun 30.
7. Czarny P, Kwiatkowski D, Toma M, Kubiak J, Sliwinska A, Talarowska M, Szemraj J, Maes M, Galecki P, Sliwinski T. Impact of Single Nucleotide Polymorphisms of Base Excision Repair Genes on DNA Damage and Efficiency of DNA Repair in Recurrent Depression Disorder. Mol Neurobiol. 2017 Aug;54(6):4150-4159. doi: 10.1007/s12035-016-9971-6. pub 2016 Jun 21
8. Czyż M, Toma M, Gajos-Michniewicz A, Majchrzak K, Hoser G, Szemraj J, Nieborowska-Skorska M, Cheng P, Gritsyuk D, Levesque M, Dummer R, Sliwinski T, Skorski T. PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas. Oncotarget. 2016; doi:10.18632/oncotarget.12270.
9. Czarny P, Kwiatkowski D, Toma M, Kubiak J, Sliwinska A, Talarowska M, Szemraj J, Maes M, Galecki P, Sliwinski T. Impact of Single Nucleotide Polymorphisms of Base Excision Repair Genes on DNA Damage and Efficiency of DNA Repair in Recurrent Depression Disorder. Mol Neurobiol. 2016 Jun 21. [Epub ahead of print] PubMed PMID: 27324896.
10. Cybula M, Wieteska Ƚ, Józefowicz-Korczyńska M, Karbownik MS, Grzelczyk WL, Szemraj J. New miRNA expression abnormalities in laryngeal squamous cell carcinoma. Cancer Biomark. 2016; 16(4):559-68.
11. Wieteska Ł, Skulimowski A, Cybula M, Szemraj J. Toxins vapC and pasB from prokaryotic TA modules remain active in mammalian cancer cells. Toxins (Basel).2014; 6(10):2948-61.
12. Balcerczyk A, Gajewska A, Macierzyńska-Piotrowska E, Pawelczyk T, Bartosz G, Szemraj J. Enhanced antioxidant capacity and anti-ageing biomarkers after diet micronutrient supplementation. Molecules. 2014; 19(9):14794-808.
13. Gałecki P, Talarowska M, Bobińska K, Szemraj J. COX-2 gene expression is correlated with cognitive function in recurrent depressive disorder. Psychiatry Res. 2014; 215(2):488-90.
14. Gałecki P, Gałecka E, Maes M, Orzechowska A, Berent D, Talarowska M, Bobińska K, Lewiński A, Bieńkiewicz M, Szemraj J. Vascular endothelial growth factor gene (VEGFA) polymorphisms may serve as prognostic factors for recurrent depressive disorder development. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 45:117-24.
15 Gałecki P, Orzechowska A, Berent D, Talarowska M, Bobińska K, Gałecka E, Lewiński A, Maes M, Szemraj J. Vascular endothelial growth factor receptor 2 gene (KDR) polymorphisms and expression levels in depressive disorder. J Affect Disord. 2013; 147(1-3):144-9.
16. Gałecki P, Gałecka E, Maes M, Chamielec M, Orzechowska A, Bobińska K, Lewiński A, Szemraj J. The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder. J Affect Disord. 2012; 138(3):360-6.
17. Martino A, Campa D, Buda G, Sainz J, García-Sanz R, Jamroziak K, Reis RM, Weinhold N, Jurado M, Ríos R, Szemraj-Rogucka Z, Marques H, Szemraj J, Stein A, Kumar R, Orciuolo E, Gemignani F, Landi S, Goldschmidt H, Petrini M, Dumontet C, Canzian F, Rossi AM. Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium. Leukemia. 2012; 26(6):1419-22.
18. Gałecki P, Maes M, Florkowski A, Lewiński A, Gałecka E, Bieńkiewicz M, Szemraj J. Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder. J Affect Disord. 2011; 129(1-3):175-82.
19. Gałecki P, Szemraj J, Bieńkiewicz M, Florkowski A, Gałecka E. Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment. Pharmacol Rep. 2009; 61(3):436-47.
20. Gałecki P, Szemraj J, Bieńkiewicz M, Zboralski K, Gałecka E. Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients. Hum Psychopharmacol. 2009; 24(4):277-86.
21. Dziedzic B, Szemraj J, Bartkowiak J, Walczewska A. Various dietary fats differentially change the gene expression of neuropeptides involved in body weight regulation in rats. J Neuroendocrinol. 2007; 19(5):364-73.

SELECTED PROJECTS COMPLETED AND CURRENTLY REALIZED: (last 10 years)
2015 – 2018 project coordinator
Project title: The role of epigenetic changes and p53 in visceral adipose tissue in the pathogenesis of type 2 diabetes mellitus, ID number of project: 2015/17/B/NZ7/03019, the project funded by the National Science Center, amount of funding: 798 600 PLN
2015 – 2018 co-investigator
Project title: The role of inflammation, oxidative, nitration stress, tryptophan catabolites pathway and base excision DNA repair in depression and the mechanism of antidepressant effect in the preclinical and clinical study in vitro, in vivo, ID number of project: 2015/19/B/NZ7/00410, the project funded by the National Science Center, amount of funding: 987 360 PLN
2013 – 2016 project coordinator
Project title: Analysis of antioxidative potential of proteins immobilized on nanoparticles. Study in vitro, in vivo, ID number of project: 2013/09/B/NZ7/01019, the project funded by the National Science Center, amount of funding: 964 277 PLN
2013 – 2016 co-investigator
Project title: MlekPlus Innovative dairy products in the prevention and mitigation of the effects of diabetes mellitus type 2, ID number of project: PBS1/B8/7/2013, the project funded by the National Centre for Research and Development, amount of funding: 4 794 900 PLN
2013 – 2015 co-investigator
Project title: The impact of combination therapy with non-steroidal anti-inflammatory drugs and inhibitors of serotonin uptake oxidative stress and selected parameters of inflammatory processes in recurrent depressive disorders., ID number of project: 2012/05/B/NZ5/11848, the project funded by the National Science Center, amount of funding: 178 000 PLN
2012 – 2015 project coordinator
Project title: Analysis of gene expression and correlation with gene polymorphic sites in primary hepatic carcinoma patients (HCC) – prognostic factor, ID number of project: 2012/05/B/NZ5/01852 , the project funded by the National Science Center, amount of funding: 479 709 PLN
2010 – 2013 co-investigator
Project title: The importance of the processes of DNA repair and gene polymorphisms mechanism for cutting nitrogen bases (BER): OGG1, XRCC1, MUTYH, ADPRT, APE1 for the development of open angle glaucoma, ID number of project: N N402 375838 , the project funded by the Ministry of Science and Higher Education, amount of funding: 231 250 PLN
2010 – 2013 project coordinator
Project title: Evaluation of activity of new additive modules addition in the context of the search for new immunotoxin, ID number of project: N N405 675340, the project funded by the Ministry of Science and Higher Education, amount of funding: 162 500 PLN
2010 – 2013 co-investigator
Project title: Molecular mechanisms of macular degeneration of the eye age-related macular degeneration (AMD), ID number of project: N N402 591340, the project funded by the Ministry of Science and Higher Education, amount of funding: 249 000 PLN
2009 – 2012 project coordinator
Project title: Analysis of expression of metalloproteinases and their inhibitors, and bone morphogenetic protein for the progression of lung cancer, ID number of project: N N402 350838, the project funded by the Ministry of Science and Higher Education, amount of funding: 265 000 PLN
2009 – 2011 co-investigator
Project title: The use of techniques for introducing siRNA into target cells through interactions with membrane receptor for the treatment of Alzheimer’s disease, ID number of project: N N405 274537, the project funded by the Ministry of Science and Higher Education, amount of funding: 265 000 PLN
2008 – 2011 co-principal investigator
Project title: Expression profile and mutations of miRNA genes- their pathogenetic and cancerogenic role in B-cell, ID number of project: NN 402178334, the project funded by the Ministry of Science and Higher Education, amount of funding: 240 000 PLN
2012 – 2014 project coordinator
Project title: Assess the impact of supplementation NucleVital®Q10COMPLEX on the condition of the body healthy women aged 35+, project ID: 507-16-304, the project funded by the Marinex Int Co, amount of funding: 150 000 PLN
2013 – 2015 project coordinator
Project title: Study of the effect of dietary supplementation with a formulation comprising an extract of seaweed Laminaria hyperborea (fucoidan content of 95%) on the immune parameters in healthy subjects aged 30-35 years, the project funded by the Marinex Int Co, amount of funding: 130 000 PLN
2002 – 2016 project coordinator
Project title: Polish Research Network “Molecular basis of phenomena of resistance”, the project funded by the Polish Academy of Science

Scientific cooperation:
• Prof. David C. Kilpatrick, Scottish National Blood Transfusion Service, Edinburgh, United Kingdom,
• Prof. M. Matsushita, Institute of Glycotechnology and Department of Applied Biochemistry, Tokai University, Kanagawa, Japan,
• Prof. Zbigniew Walaszek , prof. Malgorzata Hanausek, Department of Pharmacology, University of Texas Health Science Center, San Antonio, USA,
• Prof. Danuta Kozbor, Department of Immunology, Roswell Park Cancer Institute, New York, USA,

Professor Bogdan Walkowiak, MD, PhD graduated in physics at the University of Lodz. Immediately after graduation, he began his scientific work at the Biophysics Department of the Medical Academy in Łódź. In 1985 he received a PhD degree in natural sciences, and in 1989-90 he completed a scientific internship at the State University of New York, USA. In the following years he completed eleven short-term internships in Austria (Perkin Elmer – 1992, Pharmacia LKB – 1993, Amersham Pharmacia Biotech – 2000, 2001), Greece (Pharmacia Biotech – 1998, Amersham Biosciences – 1999, 2002), Sweden (BiaCore – 2000) , France (AlphaMos – 2009), Germany (MicroCal – 2011) and UK (GE Healthcare Lifesciences – 2011). From 1994 he was a habilitated doctor, and since 2003 a titular professor of medical sciences in the field of medical biology. Since 2000, he has been managing the Biophysics Department of the Lodz University of Technology. Until 2011 he was also employed at the Medical University of Lodz, and since 2012 he has been employed at Bionanopark Sp. z o.o. as a scientific leader of the Bionanopark laboratories, being a co-author of the BioNanoPark project, co-financed by the EU. Currently, he represents Poland in the Nanomaterials Expert Group of the European Chemicals Agency in Helsinki. He is the author / co-author of over 90 original scientific papers (Web of Science: IC – above 890, h-index – 17). He is the promoter of 10 completed PhDs. Has the co-authorship of one granted patent (P-399899) and two patent applications (P-412807, EP15461575.1). Professor’s research area includes biophysics, molecular and cell biology, the role of platelets in the coagulation system, analysis of benefits and threats resulting from the introduction of new materials and products of nanotechnology, regenerative medicine, personalized medicine – individual implants, bioeconomy.

In the years 1991-2018 he managed or was the main contractor of 15 grants, including two financed from the EU funds:
1991-1993 KBN-PL grant 4 1751 91 01/p02
1991-1994 KBN-PL grant 4 0896 91 01
1994-1996 KBN-PL grant 6 P207 024 06
1998-2001 KBN-PL grant 4 P05A 115 14
2002-2005 KBN-PL grant PBZ-KBN-082/T08/13
2003-2006 EU grant GMA1- 2002-72123 NANODIAM
2004-2005 KBN-PL grant 3T08C 056 27
2008-2009 MNiSW-PL grant N N518 362734
2008-2009 MNiSW-PL grant N N507 456034
2008-2011 MNiSW-PL grant N N401 227434
2008-2011 MNiSW-PL grant PW/P01-PBZ-MniSW/2007
2009-2011 mnt-era.net DIAHAP
2012-2016 FP7-PEOPLE-2011 grant PIAPP-GA-2011-286337
2014-2018 NCBiR grant DOB-BIO6/16/44/2014
2015-2018 NCBiR grant PBS3/244723

PUBLISHED WORKS IN THE FULL VERSION:
1. Dzieniakowski T., Jatczak J., Jedrzejewski T., Walkowiak B. Pomiary mocy prądu elektrycznego wydzielonej na rezystorze zwierającym ogniwo elektryczne powstałe u pacjentow z wypełnieniami amalgamatowymi. Czas. Stomat. 10, 905-912, 1980.
1. Jatczak J., Jedrzejewski T., Kordasz P., Szczutkowski H., Walkowiak B. Czasowe zmiany siły elektromotorycznej i natężnia prądu ogniw elektrycznych utworzonych przez dwie metalowe korony w jamie ustnej. Prot. Stomat. 2, 79-83, 1980.
2. Jatczak J., Walkowiak B. Modelowanie czasowych charakterystyk źródel prądu elektrycznego w jamie ustnej. Post. Fiz. Med. 15, 141-145, 1980.
3. Cierniewski C.S., Walkowiak B. Effect of heavy metals and alkali metals on L-leucine uptake by human blood platelets. Haemostasis, 13,234-239, 1983.
4. Dzieniakowski T., Timofiejew Z., Walkowiak B. Własna metoda pomiaru ruchomości zębów. Prot. Stomat. 2, 93-98, 1985.
5. Kozubski W., Niewiarowska J., Walkowiak B. The LA-PF4/PF4 ratio reflects the augmentation of in vivo blood platelets activity in migraine patients. Headache, 26, 298, 1986.
6. Walkowiak B., Cierniewski C.S. Kinetics of the beta-thromboglobulin release from alpha-granules of blood platelets activated by ADP. Thrombosis Research, 46, 727-736, 1987.
7. Kozubski W., Walkowiak B., Cierniewski C.S., Prusinski A. Platelet fibrinogen receptors in migraine patients. Headache, 27, 431-434, 1987.
8. Pawlowska Z., Kozubski W., Walkowiak B., Cierniewski C.S. Increased platelet glycoprotein IIb reflects an abnormality of the platelet membrane in migraine. Headache, 28, 60, 1988.
9. Walkowiak B., Cierniewski C.S. Mathematical modeling of the transport of low molecular weight solutes across biological membranes. The transport of leu, his,and glu into human blood platelets. General Physiology and Biophysics, 7, 475-494, 1988.
10. Walkowiak B., Kozubski W., Prusinski A., Cierniewski C.S. Correlation between expression of blood platelets receptors for fibrinogen and plasma cholesterol in migraine. Headache 28, 435-436, 1988.
11. Walkowiak B., Kozubski W., Pawlowska Z., Prusinski A., Cierniewski C.S. Expression of fibrinogen receptors in platelets of migraine patients-correlation with platelet GPIIb content and plasma cholesterol. Thrombosis and Haemostasis, 61, 419-422, 1989.
12. Walkowiak B., Michalak E., Koziolkiewicz W., Cierniewski C.S. Rapid photometric method for estimation of platelet count in blood plasma or platelet suspension. Thrombosis Research, 56, 763-766, 1989.
13. Walkowiak B., Kozubski W., Prusinski A., Cierniewski C.S. The increased contents of beta-thromboglobulin and fibrinogen in migraine platelets indicate an abnormality in thrombopoiesis. Headache, 29, 257, 1989.
14. Kornecki E., Walkowiak B., Naik U., Ehrlich Y.H. Activation of human platelets by a stimulatory monoclonal antibody. J. Biol. Chem. 265, 10042-10048, 1990.
15. Michalak E., Walkowiak B., Paradowski M., Cierniewski C.S. The decreased circulating platelet mass and its relation to bleeding time in chronic renal failure. Thromb. Haemost. 65, 11-14, 1991.
16. Walkowiak B., Naik U.P., Lange M., Kornecki E. Preferred use of primary radiolabeled anti-platelet monoclonal antibodies. Comparison of immunoblotting methods for the analysis of functional domains on human platelets. Thromb. Res. 68, 323-331, 1992.
17. Walkowiak B. Platelet aggregation by the monoclonal antibody F11. Interaction of F11-receptor with glycoprotein IIIa. Annales Academiae Medicae Lodzensis 34, 27-43, 1993.
18. Walkowiak B., Pawlowska Z., Michalak E., Cierniewski C.S. Expression of fibrinogen receptors on platelets of uremic patients is correlated with the content of GPIIb and plasma level of creatinine. Thromb. Haemost. 71, 164-168, 1994.
19. Walkowiak B., Michalak E., Borkowska E., Koziolkiewicz W., Cierniewski C.S. Concentration of RGDS-containing degradation products in uremic plasma is correlated with progression in renal failure. Thromb. Res. 76, 133-145, 1994.
20. Sokal A., Walkowiak B., Kaluzna A., Krol K., Cieslak M., Rychlik B., Sychowski R., Bartosz G. Stimulation of erythrocyte membrane Mg2+-ATPase activity by glutathione S-conjugates. Biochem. Molec. Biol. Int. 37, 73-79, 1995.
21. Cierniewski C.S., Walkowiak B., Niewiarowska J., Watala C., Pawlowska Z. Mechanisms of integrin receptor expression on human blood platelets. Annales Academiae Medicae Lodzensis 36, 17-24, 1995.
22. Walkowiak B., Koziolkiewicz W. Platelet activation by monoclonal antibody F11. Reconstitution of calcium influx system in liposomes. Annales Academiae Medicae Lodzensis 37; 5-17: 1995
23. Watala C., Gwozdzinski K., Pluskota E., Pietrucha T., Walkowiak B., Trojanowski T., Cierniewski C.S. Diabetes mellitus alters effect of peptide and protein ligands on membrane fluidity of blood platelets. Thromb. Haemost. 75, 147-53, 1996.
24. Watala C., Golanski B., Walkowiak B., Baj Z., Pietrucha T., Tchorzewski H., Bodalski J., Cierniewski CS. Does reduced membrane lipid fluidity underlie the altered thrombin-induced expression of integrin aIIbb3 and PADGEM-140 in membranes of platelets from diabetic juveniles? Platelets 7; 173-80: 1996.
25. Walkowiak B., Koziolkiewicz W., Michalec L., Borkowska E., Cierniewski CS. Platelet membrane fluidity and intraplatelet Ca2+ homeostasis are affected in uremia. Pol. J. Pharmacol. 48; 299-302: 1996.
26. Walkowiak B., Koziolkiewicz W., Michalec L., Pawlowska Z., Krzeslowska J., Cierniewski CS. Changes in platelet response to 5′-Diphosphate caused by verapamil. Pol. J. Pharmacol. 48; 303-5: 1996.
27. Fitzner A., Kęsy A., Niedbalski W., Paprocka G., Walkowiak B., Identyfikacja dominującego polipeptydu VP60 krajowych izolatów wirusa pomoru królików (VHD). Medycyna Wet. 52; 302-5: 1996.
28. Kęsy A., Fitzner A., Niedbalski A., Paprocka G., Walkowiak B. A new variant of the viral haemorrhagic disease of rabbits virus. Rev. sci. tech Off. int. Epiz. 15; 1029-35: 1996.
29. Kozubski W, Walkowiak B, Pawłowska Z, Prusiński A, Cierniewski CS. Blood platelet fibrinogen receptors in migraine and related headaches. Neur. Neurochir. Pol. 30; supl 2, 25-33: 1996.
30. Walkowiak B., Borkowska E., Koziolkiewicz W., Michalec L., Sobol A., Cierniewski CS. Platelet membrane fluidity and intraplatelet Ca2+ are affected in uremia. Eur. J. Haematology 58; 350-356: 1997.
31. Walkowiak B., Kesy A., Michalec L. Microplate reader – a convenient tool in studies of blood coagulation. Thromb. Res. 87; 95-103: 1997.
32. Walkowiak B. Use of the ULTROSPEC 2000 as a full range Multi-Wavelength detector for liquid chromatography. Pharmacia Biotech (Biochrom) Ltd, Application Note 53, November 98.
33. Watala C., Boncler M., Golanski J., Koziolkiewicz W., Trojanowski Z., Walkowiak B., Platelet membrane lipid fluidity and intraplatelet calcium mobilization in type-2 diabetes mellitus. Eur-J-Haematol. 61; 319-26: 1998.
34. Watala C., Boncler M., Golanski J., Koziolkiewicz W., Walkowiak B., Cierniewski CS. Release of calcium and P-Selectin from intraplatelet granules is hampered by procaine. Thromb. Res. 94; 1-11: 1999.
35. Cierniewski CS., Walkowiak B. Chromatografia powinowactwa. Ćwiczenia z biochemii, pod redakcją Klyszejko-Stefanowicz-L, PWN 1999.
36. Cierniewski CS., Walkowiak B. Chromatografia wykorzystująca hydrofobowe właściwości molekuł. Ćwiczenia z biochemii, pod redakcją Kłyszejko-Stefanowicz-L, PWN 1999.
37. Walkowiak B. Jony konieczne do życia. Gospodarka jonami wapnia w komórce i jej znaczenie dla właściwego wypełniania funkcji komórki. PANACEUM, 3(51);19-21: 1999.
38. Walkowiak B. Techniki chromatografii cieczowej. Przykłady zastosowań. Amersham Pharmacia Biotech. 2000.
39. Walkowiak B., Kralisz U., Michalec L., Majewska E., Koziolkiewicz W., Ligocka A., Cierniewski CS. Comparison of platelet aggregability and P-Selectin surface expression on platelets isolated by different methods. Thromb. Res. 99;495-502: 2000.
40. Kęsy A., Fitzner A., Niedbalski W., Paprocka G., Walkowiak B. Rabbit Haemorrhagic Disease – An animal model for Human Viral Haemorrhagic Fevers. Acta Haematologica Polonica. 31; 127-137: 2000.
41. Gorąca A., Walkowiak B. Partial purification and identification of cardiodepressant factor from the posterior pituitary lobe in rats. J. Physiol. Pharmacol. 51; 137-50: 2000.
42. Boncela J., Papiewska I., Fijalkowska I., Walkowiak B., Cierniewski CS. Acute Phase Protein alpha 1-Acid Glycoprotein Interacts with Plasminogen Activator Inhibitor Type 1 and Stabilizes Its Inhibitory Activity. J Biol Chem. 276; 35305-11: 2001.
43. Gromadzińska E., Lachowicz L., Walkowiak B., Zylinska L. Calmodulin effect on purified rat cortical plasma membrane Ca(2+)-ATPase in different phosphorylation states. Biochim Biophys Acta. 1549; 19-31: 2001.
44. Walkowiak B., Kwaszewska E., Tański W., Koziołkiewicz W. Skaza krwotoczna w przewlekłej niewydolności nerek. Diagnostyka Laboratoryjna. 37; 171-181: 2001.
45. Walkowiak B., Baraniak J., Cierniewski CS., Stec W. Inhibition of ADP-triggered blood platelet aggregation by diadenosine polyphosphate analogues. Bioorg. Med. Chem. Lett. 2002; 12: 1959-62.
46. Walkowiak B., Kochmańska V., Jakubowski W., Okrój W., Króliczak V. Interaction of body fluids with carbon surfaces. J. Wide Bandgap Materials 2002; 9: 231-42.
47. Skibska B, Okrój W, Walkowiak B. Charakterystyka płytkowych receptorów dla ADP. Post Biologii Kom 2003 1; 153-65.
48. Ćwiklińska H, Mycko MP, Luvsannorow O, Walkowiak B, Brosnan CF, Raine CS, Selmaj KW. Heat shock protein 70 associations with myelin basic protein and proteolipid protein in multiple sclerosis brains. Int Immunol. 2003; 15(2):241-249.
49. Walkowiak B, Okrój W, Przybyszewska-Doroś I, Pirek M, Szymański W, Kosenda P, Jakubowski W. Nanocrystalline diamod (NCD) – A new and promising material for medical applications. Engineering of Biomaterials 2004; 35-36: 62-67
50. Pirek M, Okrój W, Przybyszewska-Doroś I, Jakubowski W, Walkowiak B. Chemical surface modification of diamond powder particles. Engineering of Biomaterials. 2004; 35-36: 36-39
51. Okrój W, Jakubowski W, Przybyszewska I, Pirek M, Komorowski P, Szymański W, Kosenda P, Walkowiak B. Thrombocompatybility of NCD layers on a surface of tytanium alloys. Engineering of Biomaterials. 2004; 35-36: 29-32.
52. Walkowiak B. Biomedical effects of tissue contact with an implant. Engineering of Biomaterials. 2004; 38-42: 200-205.
53. Jakubowski W, Szymański W, Okrój W, Przybyszewska-Doroś I, Pirek M, Walkowiak B.
A susceptibility of biomaterial surface to bacterial colonization depends on type of this surface. Engineering of Biomaterials 2004; 38-42: 206-207.
54. Jakubowski W, Bartosz G, Niedzielski P, Szymański W, Walkowiak B. Nanocrystalline diamond surface is resistant to bacterial colonization. Diamond and Related Materials. 2004; 13(10): 1761-1763.
55. Majak J, Jakubowski W, Balcerczyk A, Niedzielski P, Walkowiak B. Changes in antioxidative capacity of fibroblasts due to a contact with selected biomaterials. Engineering of Biomaterials. 2005 43-44: 63-66.
56. Przybyszewska-Doroś I, Okrój W, Walkowiak B. Surface modifications of metallic implants. Engineering of Biomaterials. 2005; 43-44: 52-63.
57. Jerczyńska H, Barańska, Koziołkiewicz W, Walkowiak B, Pawowska Z. Growth of endothelial cells on surfaces of selected biomaterials. Engineering of Biomaterials. 2005; 43-44: 21-24.
58. Kamińska M, Szymański W, Walkowiak B. Preparation of real time SPR-biosensor for study of protein deposition at titanium and NCD surfaces. Engineering of Biomaterials. 2005; 43-44: 16-21.
59. Okrój W, Klimek L, Komorowski P, Walkowiak B. Blood platelets in contact with titanium alloy Ti6Al4V and with its modified surfaces. Engineering of Biomaterials. 2005; 43-44: 13-16
60. Szemraj J, Walkowiak B, Kawecka I, Janiszewska G, Buczko W, Bartkowiak J, Chabielska E. A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity – a staphylokinase variant. I. In vitro study. J Thromb Haemost. 2005; 3(10):2156-65.
61. Okroj W, Kaminska M, Klimek L, Szymanski W, Walkowiak B. Blood platelets in contact with nanocrystalline diamond surface. Diamond and Related Materials 2006; 15:1535-1539.
62. Walkowiak B. Potential risk associated with the use of implants NANODIAM, PWN Warszawa 2006 chapter 13:179-187.
63. Pawłowska Z, Jerczyńska H, Barańska P, Cierniewski CC, Walkowiak B. Detection of changes in cellular protein profile: a proteomics approach NANODIAM, PWN Warszawa 2006 chapter 17:215-227
64. Walkowiak B, Kaminska M, Okroj W, Tanski W, Sobol A, Zbrog Z, Przybyszewska-Doros I. Blood platelet proteome is changed in uremic patients. Platelets 2007; 18:386-388.
65. Walkowiak B. Surface-modified metallic biomaterials in contact with blood and endothelial cells Macromolecular Symposia 2007; 253:122-127.
66. Jakubowski W, Ślusarczyk A, Paszkiewicz Z, Szymański W, Walkowiak B. Bacterial colonisation of bioceramic surfaces. Advances in Applied Ceramics 2008; 107(4):217-221.
67. Walkowiak B, Okroj W, Jerczynska H, Pawlowska Z. Micron-sized diamond particles are internalized by endothelial cells. Diamond and Related Materials, 2009; 18:4, 651-656.
68. Perlikowska R, Gaha K, Fichna J, Toth G, Walkowiak B, do-Regoe JC, Janecka A. Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2. Bioorganic and Medicinal Chemistry, 2009: 17: 11, 3789-3794.
71. Okrój W, Walkowiak-Przybyło M, Rośniak-Bąk K, Klimek L, Walkowiak B. Comparison of microscopic methods for evaluating platelet adhesion to biomaterial surfaces. Acta of Bioengineering and Biomechanics 2009; Vol. 11, No. 2, 45-49.
69. Kamińska M, Okrój W, Szamański W, Jakubowski W, Komorowski P, Nosal A, Szymanowski H, Gazicki-Lipman M, Jerczyńska H, Pawłowska Z, Walkowiak B. Interaction of parylene C with biological objects. Acta of Bioengineering and Biomechanics 2009; Vol. 11, No. 3,19-25.
70. Sokolowska A, Niedzielski P, Wierzchon T, Okroj W, Urbanski S, Walkowiak B. Thrombocompatibility of thin dielectric carbon film depends on electron work function of metallic substrate material. Journal of Nanosciences and Nanotechnology, 2010; vol.10, 1367-1370.
71. Elgalal MT, Kozakiewicz M, Loba P, Walkowiak B, Olszycki M, Stefańczyk L. Patient specific implants, designed using Rapid Prototyping and diagnostic imaging, for the repair of orbital fractures. Med Sci Monit, 2010; 16(Suppl.1): 75-79.
72. Walkowiak B, Szymanski W, Szymanski J, Walczynska M, Walkowiak-Przybyło M,
Komorowski P, Okrój W, Jakubowski W, Kaminska M. SPR Biosensors Technique Supports Development in Biomaterials Engineering. In New Perspectives in Biosensors Technology and Applications/ Book 4, ed. Pier Andrea Serra, ISBN 978-953-307-448-1. June 2011.
73. Walkowiak-Przybylo M, Walczynska M, Komorowski P, Klimek L, Walkowiak B. Proliferation of human osteoblast-loke cells Saos-2 and human endothelial cells EA.hy926 on polished and sanblasted surfaces of titanium alloys Ti6Al4V and Ti6Al7Nb. Engineering of Biomaterials, 2011; 109-111, 39-41.
74. Walkowiak-Przybylo M, Okroj W, Walczynska M, Skwierczynski P, Walkowiak B. Thrombogenicity of thin layer calcium phosphate created on polished Surface of Ti6Al7Nb alloy. Engineering of Biomaterials, 2011; 109-111, 37-49.
75. Walkowiak-Przybylo M, Klimek L, Okroj W, Jakubowski J, Chwilka M, Czajka A, Walkowiak B. Adhesion, activation and aggregation of blood platelets and biofilm formation on the surface of titanium alloys Ti6Al4V and Ti6Al7Nb. Journal of Biomedical Materials Research Part A 2012; vol 100A, 768-775.
76. Sobol AB, Kaminska M, Walczynska M, Walkowiak B. Effect of Uremia and Hemodialysis on Platelet Apoptosis. Clin Appl Thromb Hemost. 2013; vol 19(3), 320-323.
77. Walkowiak B, Sobol AB, Walczynska M, Kaminska M. Effect of Uremia and Hemodialysis on Proteome Profile of Blood Platelets and Plasma. Clin Appl Thromb Hemost. 2013; vol. 19, 541-549.
78. Kozakiewicz M, Elgalal M, Walkowiak B, Stefanczyk L. Technical concept of patient-specific, ultrahigh molecular weight polyethylene orbital wall implant. Journal of Cranio-Maxillofacial Surgery, 2013; Volume: 41 Issue: 4 Pages: 282-290.
79. Walkowiak B, Okroj W, Jakubowski W, Komorowski P, Szymanski W, Chwilka M, Walkowiak-Przybylo M, Pawlowska Z, Jerczynska H. Biologiczna ocena nowych biomateriałów opracownych dla potrzeb konstrukcji i wytwarzania sztucznego serca (Biological evaluation of new biomaterials developed for the design and manufacture of artificial heart). In: Technologie inżynierii materiałowej i technologie metrologiczne dla potrzeb polskich protez serca (Materials engineering technologies and metrology technologies for Polish cardiac prostheses), Zbigniew Religa Cardiac Surgery Development Fundation, Zabrze, Poland 2013, pages: 307-342 (in Polish).
80. Walkowiak B. Nanotechnologia – korzyści i zagrożenia (Nanotechnology – the benefits and risks), Laboratorium vol. 3-4, 2014; 58-63 (in Polish).
81. Wyrebska A, Pawlowska Z, Gach K, Komorowski P, Protas A, Walkowiak B, Janecka A. Proteomic Analysis of Proteins Engaged in α-Methylene-δ-Lactone Cytotoxic Effects in Hormone-Independent Breast Cancer MDA-MB-231 Cells. Chem. Biol. Drug Des. 2014; 84: 300-306.
82. Sobczyk-Guzenda A, Owczarek S, Szymanowski H, Volesky L, Walkowiak B, Miszczak S, Gazicki-Lipman M. Iron doped thin TiO2 films synthesized with the RFPECVD method. Ceramics International 2015; 41, 7496–7500.
83. Jakubowski W, Walkowiak B. Resistance of Oxidative Stress in Biofilm and Planktonic Cells. Brazilian Archives of Biology and Technology 2015; vol 58 n2, 300-308.
84. Komorowski P, Walkowiak-Przybylo M, Walkowiak B. Early cell response to contact with biomaterial’s surface. J Biomed Mater Res Part B 2016:104B:880–893.
85. Walkowiak B, Biological evaluation of new products of innovative technology. Laboratorium. vol 3-4, 2016; 8-18.
86. Kaczorowski W, Batory D, Jakubowski W, Szymanski W, Komorowski W, Walkowiak B, Sanak M, Niedzielski P. Physicochemical and Biological Investigation of Different Structures of Carbon Coatings Deposited onto Polyurethane. Braz. Arch. Biol. Technol. v.59: e16150305, Jan/Dec 2016.
87. Kaminska M, Kuberski S, Maniukiewicz W, Owczarz P, Komorowski P, Modrzejewska Z, Walkowiak B. Thermosensitive chitosan gels containing calcium glycerophosphate for bone cell culture. Journal of Bioactive and Compatible Polymers, 2017; 32(2), 209-222.
88. Kozakiewicz M, Olbrzymek L, Stefanczyk L, Olszycki M, Komorowski P, Walkowiak B, Konieczny B, Krasowski M, Sokołowski J. Radio-opaque polyethylene for personalized craniomaxillofacial implants. Clin. Oral Invest. 2016, DOI 10.1007/s00784-016-1978-x.
89. Walkowiak-Przybyło M, Komorowski P, Walkowiak B. Differences in the expression of cell cycle genes in osteoblasts and endothelial cells cultured on the surfaces of Ti6Al4V and Ti6Al7Nb alloys. J. Biomed Mater Res Part A, 2017, 105 (6), 1607-1617
90. Staniszewski Z, Piegat A, Okroj W, Walkowiak-Przybyło M, Jakubowski W, Walkowiak B, Budner B, Mroz W, Sobolewski P, El Fray M. The effect of carbon nanoparticles on biological properties of polyester nanocomposites. Journal of Biomaterials Applications, 2017, Vol. 31(10) 1328–1336.
91. Sokolowska P, Bialkowska K, Siatkowska M, Rosowski M, Kucinska M, Komorowski P, Makowski K, Walkowiak B. Human brain endothelial barrier cells are distinctly less vulnerable to silver nanoparticles toxicity than human blood vessel cells A cell-specific mechanism of the brain barrier? Nanomedicine-Nanotechnology Biology and Medicine, 2017, Vol.13, Issue: 7, Pages: 2127-2130.
92. Jastrzębska A, Jakubowski W, Jastrzębski K, Walkowiak B. Evaluation of Candida albicans adhesion on AISI-316L and Ti6Al4V in changing environmental conditions. Engineering of Biomaterials, 2017, 141, 2-7.
93. Bartoszek N, Rosowski M, Kądzioła K, Tkacz-Szczęsna B, Siatkowska M, Działoszyńska K, Sokołowska P, Białkowska K, Urbaniak M, Elgalal M, Kołodziejczyk A, Jakubowska A, Kucińska M, Makowski K, Komorowski P, Walkowiak B. Techniki mikroskopowe w badaniach biologicznych (Microscopic techniques in biological research). Laboratorium – Przegląd Ogólnopolski. 2017, No.9-10, 12-21.

Managers

Manager of Personalized Medicine Laboratory and Biotechnological Laboratory

i.drozdz@bionanopark.pl

+48 42 280 75 41

+48 42 280 75 40

Manager of Product Authentication Laboratory

k.klajman@bionanopark.pl

+48 42 280 76 91

Manager of Molecular and Nanostructural Biophysics Laboratory as well as Nanomaterial Structural Research Laboratory

p.komorowski@bionanopark.pl

+48 42 280 76 78

Manager of Biosensor and Organic Electronics Laboratory

s.kotarba@bionanopark.pl

+48 42 280 76 84

+48 42 280 76 89

Manager of Industrial Biotechnology Laboratory

k.makowski@bionanopark.pl

+48 42 280 76 56

Deputy Manager of Molecular Simulation Laboratory

j.saramak@bionanopark.pl

+48 42 280 75 35

Scientific research employees